Healthcare - Medical - Healthcare Information Services - NASDAQ - US
$ 2.29
0.881 %
$ 61.1 M
Market Cap
-3.37
P/E
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.[ Read More ]
The intrinsic value of one BEAT stock under the base case scenario is HIDDEN Compared to the current market price of 2.29 USD, HeartBeam, Inc. is HIDDEN
2. FUNDAMENTAL
ANALYSIS
Price Chart BEAT
FINANCIALS
0
REVENUE
-15.3 M
OPERATING INCOME
-14.6 M
NET INCOME
-12.1 M
OPERATING CASH FLOW
-256 K
INVESTING CASH FLOW
25 M
FINANCING CASH FLOW
0
REVENUE
-5.07 M
OPERATING INCOME
-4.98 M
NET INCOME
-3.31 M
OPERATING CASH FLOW
-103 K
INVESTING CASH FLOW
21 K
FINANCING CASH FLOW
Balance Sheet Decomposition
HeartBeam, Inc.
| Current Assets | 16.8 M |
| Cash & Short-Term Investments | 16.2 M |
| Receivables | 0 |
| Other Current Assets | 636 K |
| Non-Current Assets | 306 K |
| Long-Term Investments | 0 |
| PP&E | 256 K |
| Other Non-Current Assets | 50 K |
| Current Liabilities | 1.19 M |
| Accounts Payable | 0 |
| Short-Term Debt | 0 |
| Other Current Liabilities | 1.19 M |
| Non-Current Liabilities | 0 |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 0 |
EFFICIENCY
Earnings Waterfall
HeartBeam, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 15.3 M |
| Operating Income | -15.3 M |
| Other Expenses | -675 K |
| Net Income | -14.6 M |
RATIOS
0.00%
GROSS MARGIN
0.00%
OPERATING MARGIN
0.00%
NET MARGIN
-91.86%
ROE
-85.45%
ROA
-96.09%
ROIC
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
HeartBeam, Inc.
| Net Income | -14.6 M |
| Depreciation & Amortization | 15.3 M |
| Capital Expenditures | -256 K |
| Stock-Based Compensation | 3.21 M |
| Change in Working Capital | -662 K |
| Others | -191 K |
| Free Cash Flow | -12.3 M |
Wall Street Analysts Price Targets
HeartBeam, Inc.
BEAT has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
0.00%
DIVIDEND YIELD
0 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
HeartBeam, Inc.
Sold
0-3 MONTHS
28 K USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|---|---|---|---|
|
2 months ago
Sep 06, 2024
|
Sell 3.92 K USD
|
de Urioste George
Director |
- 1674
|
2.34 USD |
|
2 months ago
Aug 30, 2024
|
Sell 12.7 K USD
|
de Urioste George
Director |
- 5500
|
2.31 USD |
|
2 months ago
Aug 27, 2024
|
Sell 4.96 K USD
|
de Urioste George
Director |
- 2194
|
2.26 USD |
|
2 months ago
Aug 23, 2024
|
Sell 5.75 K USD
|
de Urioste George
Director |
- 2500
|
2.3 USD |
|
2 months ago
Aug 26, 2024
|
Sell 714 USD
|
de Urioste George
Director |
- 300
|
2.38 USD |
|
1 year ago
Sep 29, 2023
|
Sell 11.3 K USD
|
de Urioste George
Director |
- 5500
|
2.06 USD |
|
1 year ago
Sep 27, 2023
|
Sell 3.87 K USD
|
de Urioste George
Director |
- 1834
|
2.11 USD |
|
1 year ago
Sep 28, 2023
|
Sell 16.3 K USD
|
de Urioste George
Director |
- 8000
|
2.04 USD |
|
1 year ago
Sep 22, 2023
|
Sell 5.29 K USD
|
de Urioste George
Director |
- 2393
|
2.21 USD |
|
1 year ago
Sep 26, 2023
|
Sell 10.4 K USD
|
de Urioste George
Director |
- 5000
|
2.09 USD |
|
1 year ago
Sep 20, 2023
|
Sell 2.17 K USD
|
de Urioste George
Director |
- 883
|
2.46 USD |
|
1 year ago
Sep 21, 2023
|
Sell 241 USD
|
de Urioste George
Director |
- 100
|
2.41 USD |
|
1 year ago
Sep 15, 2023
|
Sell 10.4 K USD
|
de Urioste George
Director |
- 4269
|
2.43 USD |
|
1 year ago
Sep 18, 2023
|
Sell 12.3 K USD
|
de Urioste George
Director |
- 5000
|
2.46 USD |
|
1 year ago
Sep 13, 2023
|
Sell 3.57 K USD
|
de Urioste George
Director |
- 1878
|
1.9 USD |
|
1 year ago
Sep 13, 2023
|
Sell 6.09 K USD
|
de Urioste George
Director |
- 3122
|
1.95 USD |
|
1 year ago
Sep 14, 2023
|
Sell 10.8 K USD
|
de Urioste George
Director |
- 5000
|
2.17 USD |
|
2 years ago
Mar 30, 2022
|
Bought 0 USD
|
Brounstein Richard
Chief Financial Officer |
+ 10000
|
0 USD |
|
2 years ago
Mar 29, 2022
|
Bought 0 USD
|
Vajdic Branislav
Chief Executive Officer |
+ 10000
|
0 USD |
|
2 years ago
Dec 30, 2021
|
Bought 0 USD
|
Vajdic Branislav
Chief Executive Officer |
+ 25000
|
0 USD |
|
2 years ago
Dec 30, 2021
|
Bought 0 USD
|
Vajdic Branislav
Chief Executive Officer |
+ 25000
|
0 USD |
|
2 years ago
Dec 21, 2021
|
Bought 0 USD
|
Elfrink Willhem
Director |
+ 10000
|
0 USD |
|
2 years ago
Dec 21, 2021
|
Bought 16.8 K USD
|
BROUNSTEIN RICHARD D
Chief Financial Officer |
+ 5000
|
3.3692 USD |
|
3 years ago
Nov 11, 2021
|
Bought 30 K USD
|
BROUNSTEIN RICHARD D
CHIEF FINANCIAL OFFICER |
+ 5000
|
5.99 USD |
|
3 years ago
Nov 11, 2021
|
Bought 53.9 K USD
|
Ortigas-Wedekind Marga
Director |
+ 9000
|
5.99 USD |
|
4 years ago
Dec 31, 2019
|
Sell 236 K USD
|
Ferola Peter
SVP & General Counsel |
- 5065
|
46.62 USD |
|
5 years ago
Sep 04, 2019
|
Sell 1.73 M USD
|
Ferola Peter
SVP & General Counsel |
- 44276
|
39.03 USD |
|
5 years ago
May 03, 2019
|
Sell 296 K USD
|
GORMAN KIRK E
Director |
- 5518
|
53.69 USD |
|
5 years ago
Apr 30, 2019
|
Sell 300 K USD
|
GORMAN KIRK E
Director |
- 5518
|
54.37 USD |
|
6 years ago
Nov 01, 2018
|
Sell 4.55 M USD
|
Ferola Peter
SVP & General Counsel |
- 75000
|
60.61 USD |
|
6 years ago
Sep 28, 2018
|
Sell 5.86 M USD
|
Broadway Fred
President BioTel Heart |
- 90113
|
65 USD |
|
6 years ago
Oct 01, 2018
|
Sell 40.7 K USD
|
GORMAN KIRK E
Director |
- 625
|
65.07 USD |
|
6 years ago
Sep 17, 2018
|
Sell 38.9 K USD
|
GORMAN KIRK E
Director |
- 625
|
62.3 USD |
|
6 years ago
Jul 26, 2018
|
Sell 11.3 M USD
|
Capper Joseph H
President & CEO |
- 209154
|
54.26 USD |
|
6 years ago
Jul 27, 2018
|
Sell 4.83 M USD
|
Capper Joseph H
President & CEO |
- 90846
|
53.14 USD |
|
6 years ago
Jul 23, 2018
|
Sell 381 K USD
|
GORMAN KIRK E
Director |
- 7500
|
50.74 USD |
|
6 years ago
Jul 02, 2018
|
Sell 341 K USD
|
GORMAN KIRK E
Director |
- 7500
|
45.49 USD |
|
6 years ago
Jun 13, 2018
|
Sell 2.91 M USD
|
Capper Joseph H
President & CEO |
- 65787
|
44.18 USD |
|
6 years ago
Jun 12, 2018
|
Sell 3.48 M USD
|
Capper Joseph H
President & CEO |
- 79292
|
43.88 USD |
|
6 years ago
Jun 11, 2018
|
Sell 2.39 M USD
|
Capper Joseph H
President & CEO |
- 54921
|
43.45 USD |
|
6 years ago
May 11, 2018
|
Sell 2.72 M USD
|
Ferola Peter
SVP & General Counsel |
- 67370
|
40.42 USD |
|
6 years ago
Mar 13, 2018
|
Sell 1.85 M USD
|
Broadway Fred
President BioTel Heart |
- 54158
|
34.17 USD |
|
7 years ago
Mar 20, 2017
|
Sell 92.2 K USD
|
Broadway Fred
SVP - Sales Marketing |
- 3429
|
26.9 USD |
|
7 years ago
Feb 21, 2017
|
Sell 200 K USD
|
Broadway Fred
SVP - Sales Marketing |
- 8070
|
24.81 USD |
|
8 years ago
Sep 19, 2016
|
Sell 21.3 K USD
|
Broadway Fred
SVP - Sales Marketing |
- 1151
|
18.5 USD |
|
8 years ago
Sep 13, 2016
|
Sell 79.3 K USD
|
Ferola Peter
General Counsel |
- 4352
|
18.23 USD |
|
8 years ago
Sep 13, 2016
|
Sell 489 K USD
|
Capper Joseph H
President and CEO |
- 26847
|
18.23 USD |
|
8 years ago
Sep 09, 2016
|
Sell 56.1 K USD
|
Broadway Fred
SVP - Sales Marketing |
- 3146
|
17.84 USD |
|
8 years ago
Sep 08, 2016
|
Sell 40 K USD
|
Ferola Peter
General Counsel |
- 2210
|
18.1 USD |
|
8 years ago
Sep 08, 2016
|
Sell 51.2 K USD
|
Broadway Fred
SVP - Sales Marketing |
- 2837
|
18.06 USD |
|
8 years ago
Sep 08, 2016
|
Sell 247 K USD
|
Capper Joseph H
President and CEO |
- 13632
|
18.1 USD |
|
8 years ago
Sep 07, 2016
|
Sell 78.5 K USD
|
Ferola Peter
General Counsel |
- 4237
|
18.52 USD |
|
8 years ago
Sep 02, 2016
|
Sell 23.3 K USD
|
Ferola Peter
General Counsel |
- 1241
|
18.75 USD |
|
8 years ago
Sep 06, 2016
|
Sell 90.7 K USD
|
Ferola Peter
General Counsel |
- 4960
|
18.29 USD |
|
8 years ago
Sep 02, 2016
|
Sell 562 K USD
|
Capper Joseph H
President and CEO |
- 29953
|
18.75 USD |
|
8 years ago
Sep 06, 2016
|
Sell 560 K USD
|
Capper Joseph H
President and CEO |
- 30595
|
18.29 USD |
|
8 years ago
Sep 07, 2016
|
Sell 484 K USD
|
Capper Joseph H
President and CEO |
- 26133
|
18.52 USD |
|
8 years ago
Sep 02, 2016
|
Sell 83.7 K USD
|
Broadway Fred
SVP - Sales Marketing |
- 4466
|
18.75 USD |
|
8 years ago
Sep 06, 2016
|
Sell 85.2 K USD
|
Broadway Fred
SVP - Sales Marketing |
- 4662
|
18.28 USD |
|
8 years ago
Sep 07, 2016
|
Sell 71.2 K USD
|
Broadway Fred
SVP - Sales Marketing |
- 3848
|
18.51 USD |
|
8 years ago
Aug 31, 2016
|
Sell 48.2 K USD
|
Broadway Fred
SVP - Sales Marketing |
- 2614
|
18.45 USD |
|
8 years ago
Sep 01, 2016
|
Sell 96.6 K USD
|
Broadway Fred
SVP - Sales Marketing |
- 4911
|
19.67 USD |
|
8 years ago
Aug 31, 2016
|
Sell 51.6 K USD
|
Ferola Peter
General Counsel |
- 2797
|
18.45 USD |
|
8 years ago
Sep 01, 2016
|
Sell 91.9 K USD
|
Ferola Peter
General Counsel |
- 4925
|
18.67 USD |
|
8 years ago
Aug 31, 2016
|
Sell 318 K USD
|
Capper Joseph H
President and CEO |
- 17247
|
18.45 USD |
|
8 years ago
Sep 01, 2016
|
Sell 567 K USD
|
Capper Joseph H
President and CEO |
- 30375
|
18.67 USD |
|
8 years ago
Aug 26, 2016
|
Sell 91.6 K USD
|
Broadway Fred
SVP - Sales Marketing |
- 4772
|
19.2 USD |
|
8 years ago
Aug 29, 2016
|
Sell 96.7 K USD
|
Broadway Fred
SVP - Sales Marketing |
- 5105
|
18.95 USD |
|
8 years ago
Aug 30, 2016
|
Sell 42.8 K USD
|
Broadway Fred
SVP - Sales Marketing |
- 2244
|
19.07 USD |
|
8 years ago
Aug 26, 2016
|
Sell 98 K USD
|
Ferola Peter
General Counsel |
- 5106
|
19.2 USD |
|
8 years ago
Aug 29, 2016
|
Sell 104 K USD
|
Ferola Peter
General Counsel |
- 5462
|
18.95 USD |
|
8 years ago
Aug 30, 2016
|
Sell 45.8 K USD
|
Ferola Peter
General Counsel |
- 2402
|
19.07 USD |
|
8 years ago
Aug 26, 2016
|
Sell 605 K USD
|
Capper Joseph H
President and CEO |
- 31489
|
19.2 USD |
|
8 years ago
Aug 29, 2016
|
Sell 638 K USD
|
Capper Joseph H
President and CEO |
- 33686
|
18.95 USD |
|
8 years ago
Aug 30, 2016
|
Sell 282 K USD
|
Capper Joseph H
President and CEO |
- 14811
|
19.07 USD |
|
8 years ago
Aug 25, 2016
|
Sell 120 K USD
|
Ferola Peter
General Counsel |
- 6289
|
19.16 USD |
|
8 years ago
Aug 25, 2016
|
Sell 743 K USD
|
Capper Joseph H
President and CEO |
- 38785
|
19.16 USD |
|
8 years ago
Aug 25, 2016
|
Sell 113 K USD
|
Broadway Fred
SVP - Sales Marketing |
- 5877
|
19.16 USD |
|
8 years ago
Aug 22, 2016
|
Sell 75.4 K USD
|
Ferola Peter
General Counsel |
- 3616
|
20.85 USD |
|
8 years ago
Aug 23, 2016
|
Sell 57 K USD
|
Ferola Peter
General Counsel |
- 2758
|
20.67 USD |
|
8 years ago
Aug 24, 2016
|
Sell 131 K USD
|
Ferola Peter
General Counsel |
- 6512
|
20.11 USD |
|
8 years ago
Aug 22, 2016
|
Sell 465 K USD
|
Capper Joseph H
President and CEO |
- 22298
|
20.85 USD |
|
8 years ago
Aug 23, 2016
|
Sell 352 K USD
|
Capper Joseph H
President and CEO |
- 17008
|
20.67 USD |
|
8 years ago
Aug 24, 2016
|
Sell 808 K USD
|
Capper Joseph H
President and CEO |
- 40160
|
20.11 USD |
|
8 years ago
Aug 22, 2016
|
Sell 70.5 K USD
|
Broadway Fred
SVP - Sales Marketing |
- 3379
|
20.85 USD |
|
8 years ago
Aug 23, 2016
|
Sell 53.3 K USD
|
Broadway Fred
SVP - Sales Marketing |
- 2578
|
20.67 USD |
|
8 years ago
Aug 24, 2016
|
Sell 122 K USD
|
Broadway Fred
SVP - Sales Marketing |
- 6086
|
20.11 USD |
|
8 years ago
Aug 19, 2016
|
Sell 189 K USD
|
Ferola Peter
General Counsel |
- 9035
|
20.96 USD |
|
8 years ago
Aug 19, 2016
|
Sell 190 K USD
|
Broadway Fred
SVP - Sales Marketing |
- 9049
|
20.96 USD |
|
8 years ago
Aug 19, 2016
|
Sell 190 K USD
|
Capper Joseph H
President and CEO |
- 9049
|
20.96 USD |
|
10 years ago
May 09, 2014
|
Bought 47.5 K USD
|
GORMAN KIRK E
Director |
+ 6500
|
7.31 USD |
|
10 years ago
Nov 22, 2013
|
Sell 13.3 K USD
|
PRYSTOWSKY ERIC N
Director |
- 1250
|
10.655 USD |
|
12 years ago
Sep 05, 2012
|
Bought 23.3 K USD
|
Capper Joseph H
President and CEO |
+ 10745
|
2.17 USD |
|
12 years ago
Sep 04, 2012
|
Bought 29.7 K USD
|
Capper Joseph H
President and CEO |
+ 12795
|
2.32 USD |
|
12 years ago
Aug 31, 2012
|
Bought 5.93 K USD
|
Capper Joseph H
President and CEO |
+ 2600
|
2.28 USD |
|
12 years ago
Aug 29, 2012
|
Bought 14.4 K USD
|
Capper Joseph H
President and CEO |
+ 6200
|
2.33 USD |
|
12 years ago
Aug 29, 2012
|
Bought 10.4 K USD
|
Capper Joseph H
President and CEO |
+ 4600
|
2.27 USD |
|
12 years ago
Aug 28, 2012
|
Bought 2.85 K USD
|
Capper Joseph H
President and CEO |
+ 1300
|
2.19 USD |
|
12 years ago
Aug 27, 2012
|
Bought 3.39 K USD
|
Capper Joseph H
President and CEO |
+ 1600
|
2.12 USD |
|
12 years ago
Aug 24, 2012
|
Bought 1.7 K USD
|
Capper Joseph H
President and CEO |
+ 800
|
2.13 USD |
|
12 years ago
Aug 23, 2012
|
Bought 2.32 K USD
|
Capper Joseph H
President and CEO |
+ 1100
|
2.11 USD |
|
12 years ago
Aug 22, 2012
|
Bought 17.7 K USD
|
Capper Joseph H
President and CEO |
+ 8500
|
2.08 USD |
|
12 years ago
Aug 21, 2012
|
Bought 1.61 K USD
|
Capper Joseph H
President and CEO |
+ 800
|
2.01 USD |
|
12 years ago
Aug 20, 2012
|
Bought 27.9 K USD
|
Capper Joseph H
President and CEO |
+ 14160
|
1.97 USD |
|
12 years ago
Aug 17, 2012
|
Bought 20.6 K USD
|
Capper Joseph H
President and CEO |
+ 9800
|
2.1 USD |
|
15 years ago
May 15, 2009
|
Bought 9.9 K USD
|
PRYSTOWSKY ERIC N
Director |
+ 550
|
18 USD |
|
15 years ago
May 15, 2009
|
Bought 16.5 K USD
|
GALVAN MARTIN P
Chief Financial Officer |
+ 900
|
18.33 USD |
|
15 years ago
May 15, 2009
|
Bought 1.84 K USD
|
GALVAN MARTIN P
Chief Financial Officer |
+ 100
|
18.4 USD |
|
15 years ago
May 15, 2009
|
Bought 1.1 K USD
|
GALVAN MARTIN P
Chief Financial Officer |
+ 60
|
18.41 USD |
|
15 years ago
May 15, 2009
|
Bought 1.84 K USD
|
GALVAN MARTIN P
Chief Financial Officer |
+ 100
|
18.42 USD |
|
15 years ago
May 15, 2009
|
Bought 1.84 K USD
|
GALVAN MARTIN P
Chief Financial Officer |
+ 100
|
18.43 USD |
|
15 years ago
May 15, 2009
|
Bought 1.84 K USD
|
GALVAN MARTIN P
Chief Financial Officer |
+ 100
|
18.41 USD |
|
15 years ago
May 15, 2009
|
Bought 6.27 K USD
|
GALVAN MARTIN P
Chief Financial Officer |
+ 340
|
18.43 USD |
|
15 years ago
May 15, 2009
|
Bought 3.69 K USD
|
GALVAN MARTIN P
Chief Financial Officer |
+ 200
|
18.44 USD |
|
15 years ago
May 15, 2009
|
Bought 3.69 K USD
|
GALVAN MARTIN P
Chief Financial Officer |
+ 200
|
18.43 USD |
|
15 years ago
May 15, 2009
|
Bought 53.5 K USD
|
GALVAN MARTIN P
Chief Financial Officer |
+ 2900
|
18.45 USD |
|
15 years ago
May 15, 2009
|
Bought 11.1 K USD
|
GORMAN KIRK E
Director |
+ 600
|
18.5 USD |
|
15 years ago
May 14, 2009
|
Bought 7.2 K USD
|
GORMAN KIRK E
Director |
+ 400
|
18 USD |
|
15 years ago
May 12, 2009
|
Bought 43.8 K USD
|
GORMAN KIRK E
Director |
+ 2500
|
17.53 USD |
|
15 years ago
May 05, 2009
|
Bought 32.1 K USD
|
THURMAN RANDY H
Chairman, President & CEO |
+ 1785
|
18 USD |
|
15 years ago
May 05, 2009
|
Bought 1.8 K USD
|
THURMAN RANDY H
Chairman, President & CEO |
+ 100
|
17.99 USD |
|
15 years ago
May 05, 2009
|
Bought 5.39 K USD
|
THURMAN RANDY H
Chairman, President & CEO |
+ 300
|
17.98 USD |
|
15 years ago
May 05, 2009
|
Bought 1.8 K USD
|
THURMAN RANDY H
Chairman, President & CEO |
+ 100
|
17.97 USD |
|
15 years ago
May 05, 2009
|
Bought 1.8 K USD
|
THURMAN RANDY H
Chairman, President & CEO |
+ 100
|
17.96 USD |
|
15 years ago
May 05, 2009
|
Bought 35.4 K USD
|
THURMAN RANDY H
Chairman, President & CEO |
+ 1970
|
17.95 USD |
|
15 years ago
May 05, 2009
|
Bought 1.79 K USD
|
THURMAN RANDY H
Chairman, President & CEO |
+ 100
|
17.94 USD |
|
15 years ago
May 05, 2009
|
Bought 19.7 K USD
|
THURMAN RANDY H
Chairman, President & CEO |
+ 1100
|
17.93 USD |
|
15 years ago
Feb 26, 2009
|
Sell 9.65 K USD
|
MIDDLETON FRED A
Director |
- 370
|
26.09 USD |
|
15 years ago
Feb 26, 2009
|
Sell 261 USD
|
MIDDLETON FRED A
Director |
- 10
|
26.06 USD |
|
15 years ago
Feb 26, 2009
|
Sell 1.25 K USD
|
MIDDLETON FRED A
Director |
- 48
|
26.05 USD |
|
15 years ago
Feb 26, 2009
|
Sell 1.35 K USD
|
MIDDLETON FRED A
Director |
- 52
|
26.03 USD |
|
15 years ago
Feb 26, 2009
|
Sell 7.52 K USD
|
MIDDLETON FRED A
Director |
- 289
|
26.02 USD |
|
15 years ago
Feb 26, 2009
|
Sell 2.73 K USD
|
MIDDLETON FRED A
Director |
- 105
|
26.01 USD |
|
15 years ago
Feb 26, 2009
|
Sell 25.6 K USD
|
MIDDLETON FRED A
Director |
- 984
|
26 USD |
|
15 years ago
Feb 26, 2009
|
Sell 6.83 K USD
|
MIDDLETON FRED A
Director |
- 264
|
25.89 USD |
|
15 years ago
Feb 26, 2009
|
Sell 1.35 K USD
|
MIDDLETON FRED A
Director |
- 52
|
25.88 USD |
|
15 years ago
Feb 26, 2009
|
Sell 2.72 K USD
|
MIDDLETON FRED A
Director |
- 105
|
25.87 USD |
|
15 years ago
Feb 26, 2009
|
Sell 3.13 K USD
|
MIDDLETON FRED A
Director |
- 121
|
25.86 USD |
|
15 years ago
Feb 26, 2009
|
Sell 30.8 K USD
|
MIDDLETON FRED A
Director |
- 1190
|
25.85 USD |
|
15 years ago
Feb 26, 2009
|
Sell 4.08 K USD
|
MIDDLETON FRED A
Director |
- 158
|
25.84 USD |
|
15 years ago
Feb 26, 2009
|
Sell 2.71 K USD
|
MIDDLETON FRED A
Director |
- 105
|
25.83 USD |
|
15 years ago
Feb 26, 2009
|
Sell 1.34 K USD
|
MIDDLETON FRED A
Director |
- 52
|
25.82 USD |
|
15 years ago
Feb 26, 2009
|
Sell 10.9 K USD
|
MIDDLETON FRED A
Director |
- 423
|
25.81 USD |
|
15 years ago
Feb 26, 2009
|
Sell 68.3 K USD
|
MIDDLETON FRED A
Director |
- 2649
|
25.8 USD |
|
15 years ago
Feb 26, 2009
|
Sell 1.34 K USD
|
MIDDLETON FRED A
Director |
- 52
|
25.79 USD |
|
15 years ago
Feb 26, 2009
|
Sell 4.07 K USD
|
MIDDLETON FRED A
Director |
- 158
|
25.77 USD |
|
15 years ago
Feb 26, 2009
|
Sell 19.1 K USD
|
MIDDLETON FRED A
Director |
- 741
|
25.76 USD |
|
15 years ago
Feb 26, 2009
|
Sell 1.24 K USD
|
MIDDLETON FRED A
Director |
- 48
|
25.79 USD |
|
15 years ago
Feb 26, 2009
|
Sell 3.66 K USD
|
MIDDLETON FRED A
Director |
- 142
|
25.77 USD |
|
15 years ago
Feb 26, 2009
|
Sell 17 K USD
|
MIDDLETON FRED A
Director |
- 659
|
25.76 USD |
|
15 years ago
Feb 26, 2009
|
Sell 146 K USD
|
MIDDLETON FRED A
Director |
- 5670
|
25.75 USD |
|
15 years ago
Feb 26, 2009
|
Sell 130 K USD
|
MIDDLETON FRED A
Director |
- 5031
|
25.75 USD |
|
15 years ago
Feb 26, 2009
|
Sell 8.61 K USD
|
MIDDLETON FRED A
Director |
- 330
|
26.09 USD |
|
15 years ago
Feb 26, 2009
|
Sell 287 USD
|
MIDDLETON FRED A
Director |
- 11
|
26.06 USD |
|
15 years ago
Feb 26, 2009
|
Sell 1.17 K USD
|
MIDDLETON FRED A
Director |
- 45
|
26.05 USD |
|
15 years ago
Feb 26, 2009
|
Sell 1.25 K USD
|
MIDDLETON FRED A
Director |
- 48
|
26.03 USD |
|
15 years ago
Feb 26, 2009
|
Sell 6.74 K USD
|
MIDDLETON FRED A
Director |
- 259
|
26.02 USD |
|
15 years ago
Feb 26, 2009
|
Sell 2.47 K USD
|
MIDDLETON FRED A
Director |
- 95
|
26.01 USD |
|
15 years ago
Feb 26, 2009
|
Sell 22.8 K USD
|
MIDDLETON FRED A
Director |
- 875
|
26 USD |
|
15 years ago
Feb 26, 2009
|
Sell 6.11 K USD
|
MIDDLETON FRED A
Director |
- 236
|
25.89 USD |
|
15 years ago
Feb 26, 2009
|
Sell 1.24 K USD
|
MIDDLETON FRED A
Director |
- 48
|
25.88 USD |
|
15 years ago
Feb 26, 2009
|
Sell 2.46 K USD
|
MIDDLETON FRED A
Director |
- 95
|
25.87 USD |
|
15 years ago
Feb 26, 2009
|
Sell 2.82 K USD
|
MIDDLETON FRED A
Director |
- 109
|
25.86 USD |
|
15 years ago
Feb 26, 2009
|
Sell 27.3 K USD
|
MIDDLETON FRED A
Director |
- 1058
|
25.85 USD |
|
15 years ago
Feb 26, 2009
|
Sell 3.67 K USD
|
MIDDLETON FRED A
Director |
- 142
|
25.84 USD |
|
15 years ago
Feb 26, 2009
|
Sell 2.45 K USD
|
MIDDLETON FRED A
Director |
- 95
|
25.83 USD |
|
15 years ago
Feb 26, 2009
|
Sell 1.24 K USD
|
MIDDLETON FRED A
Director |
- 48
|
25.82 USD |
|
15 years ago
Feb 26, 2009
|
Sell 9.73 K USD
|
MIDDLETON FRED A
Director |
- 377
|
25.81 USD |
|
15 years ago
Feb 26, 2009
|
Sell 60.7 K USD
|
MIDDLETON FRED A
Director |
- 2351
|
25.8 USD |
|
15 years ago
Feb 27, 2009
|
Bought 10 K USD
|
GALVAN MARTIN P
Chief Financial Officer |
+ 400
|
25.059 USD |
|
15 years ago
Feb 27, 2009
|
Bought 2.5 K USD
|
GALVAN MARTIN P
Chief Financial Officer |
+ 100
|
25.05 USD |
|
15 years ago
Feb 27, 2009
|
Bought 2.5 K USD
|
GALVAN MARTIN P
Chief Financial Officer |
+ 100
|
25.023 USD |
|
15 years ago
Feb 27, 2009
|
Bought 10 K USD
|
GALVAN MARTIN P
Chief Financial Officer |
+ 400
|
24.996 USD |
|
15 years ago
Feb 20, 2009
|
Sell 10.9 K USD
|
PRYSTOWSKY ERIC N
Director |
- 400
|
27.17 USD |
|
15 years ago
Feb 20, 2009
|
Sell 170 K USD
|
PRYSTOWSKY ERIC N
Director |
- 6300
|
26.92 USD |
|
15 years ago
Feb 20, 2009
|
Sell 133 K USD
|
PRYSTOWSKY ERIC N
Director |
- 5000
|
26.68 USD |
|
15 years ago
Feb 20, 2009
|
Sell 142 K USD
|
PRYSTOWSKY ERIC N
Director |
- 5204
|
27.27 USD |
|
16 years ago
Nov 19, 2008
|
Sell 41.9 K USD
|
PRYSTOWSKY ERIC N
Director |
- 2000
|
20.95 USD |
|
16 years ago
Nov 19, 2008
|
Sell 41.9 K USD
|
PRYSTOWSKY ERIC N
Director |
- 2000
|
20.97 USD |
|
16 years ago
Nov 19, 2008
|
Sell 21 K USD
|
PRYSTOWSKY ERIC N
Director |
- 1000
|
20.98 USD |
|
16 years ago
Nov 19, 2008
|
Sell 21 K USD
|
PRYSTOWSKY ERIC N
Director |
- 1000
|
20.984 USD |
|
16 years ago
Sep 15, 2008
|
Sell 266 K USD
|
PRYSTOWSKY ERIC N
Director |
- 10000
|
26.5893 USD |
|
16 years ago
Sep 16, 2008
|
Sell 559 K USD
|
PRYSTOWSKY ERIC N
Director |
- 21090
|
26.515 USD |
|
16 years ago
Aug 06, 2008
|
Sell 3.42 M USD
|
Sanderling Venture Partners IV, L.P.
10 percent owner |
- 128881
|
26.5 USD |
|
16 years ago
Aug 06, 2008
|
Sell 2.14 M USD
|
Sanderling Venture Partners IV, L.P.
10 percent owner |
- 80627
|
26.5 USD |
|
16 years ago
Aug 06, 2008
|
Sell 2.13 M USD
|
Sanderling Venture Partners IV, L.P.
10 percent owner |
- 80455
|
26.5 USD |
|
16 years ago
Aug 06, 2008
|
Sell 1.71 M USD
|
Sanderling Venture Partners IV, L.P.
10 percent owner |
- 64434
|
26.5 USD |
|
16 years ago
Aug 06, 2008
|
Sell 324 K USD
|
Sanderling Venture Partners IV, L.P.
10 percent owner |
- 12230
|
26.5 USD |
|
16 years ago
Aug 06, 2008
|
Sell 608 K USD
|
Sanderling Venture Partners IV, L.P.
10 percent owner |
- 22929
|
26.5 USD |
|
16 years ago
Aug 06, 2008
|
Sell 5.48 M USD
|
Sanderling Venture Partners IV, L.P.
10 percent owner |
- 206668
|
26.5 USD |
|
16 years ago
Aug 06, 2008
|
Sell 3.75 M USD
|
Sanderling Venture Partners IV, L.P.
10 percent owner |
- 141521
|
26.5 USD |
|
16 years ago
Aug 06, 2008
|
Sell 3.31 M USD
|
Sanderling Venture Partners IV, L.P.
10 percent owner |
- 124948
|
26.5 USD |
|
16 years ago
Aug 06, 2008
|
Sell 2.27 M USD
|
Sanderling Venture Partners IV, L.P.
10 percent owner |
- 85818
|
26.5 USD |
7. News
HeartBeam, Inc. (BEAT) Q3 2024 Earnings Call Transcript
HeartBeam, Inc. (NASDAQ:BEAT ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Rob Eno - Chief Executive Officer Branislav Vajdic - President and Founder Tim Cruickshank - Chief Financial Officer Conference Call Participants Operator Greetings, and welcome to the HeartBeam Third Quarter 2024 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
seekingalpha.com
- 1 week ago
HeartBeam Reports Third Quarter 2024 Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Third Quarter 2024 Results.
businesswire.com
- 1 week ago
HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time.
businesswire.com
- 2 weeks ago
HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards.
businesswire.com
- 3 weeks ago
HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization.
businesswire.com
- 1 month ago
HeartBeam, Inc. (BEAT) Q2 2024 Earnings Call Transcript
HeartBeam, Inc. (NASDAQ:BEAT ) Q2 2024 Earnings Conference Call August 14, 2024 4:30 PM ET Company Participants Branislav Vajdic - Founder and CEO Rob Eno - President Ravi Malhotra - Senior Director, Corporate Controller Conference Call Participants Operator Greetings, and welcome to the HeartBeam Second Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
seekingalpha.com
- 3 months ago
Epitel Announces Appointment of Wearables Industry Leader Ken Nelson to Board of Directors
SALT LAKE CITY--(BUSINESS WIRE)--Epitel, a leader in AI technologies for patient-focused brain health solutions, announced today the addition of wearables industry pioneer Ken Nelson to its Board of Directors. With his extensive experience in digital health, medical devices, and remote patient monitoring, Nelson will play a crucial role in guiding Epitel's growth as the company continues to transform the landscape of brain monitoring through AI/ML and its wearable EEG technology. Ken Nelson bri.
businesswire.com
- 4 months ago
Syndax Presents Updated Positive Data from BEAT AML and AUGMENT-102 Phase 1/2 Combination Trials of Revumenib in Patients with Acute Leukemias at EHA 2024 Congress
- Data continue to support revumenib's potential to enhance current standard of care agents - - 96% CRc (23 of 24 pts) observed in BEAT AML trial exploring revumenib in combination with venetoclax/azacitidine in newly diagnosed mNPM1 or KMT2Ar AML - - 52% CRc (14 of 27 pts) observed in AUGMENT-102 trial of revumenib in combination with fludarabine-cytarabine in acute leukemia patients with R/R mNPM1, NUP98r or KMT2Ar - WALTHAM, Mass. , June 14, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced updated data from multiple combination trials of revumenib, the Company's potent, selective, small molecule menin inhibitor, in patients with acute leukemias.
prnewswire.com
- 5 months ago
HeartBeam's Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam's Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias.
businesswire.com
- 5 months ago
HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program.
businesswire.com
- 6 months ago
HeartBeam, Inc. (BEAT) Q1 2024 Earnings Call Transcript
HeartBeam, Inc. (NASDAQ:BEAT ) Q1 2024 Earnings Conference Call May 9, 2024 4:30 PM ET Company Participants Branislav Vajdic - Founder and CEO Rob Eno - President Rick Brounstein - Consulting Chief Financial Officer Brooks Hamilton - Investor Relations, MZ Group Conference Call Participants Leo Carpio - Joseph Gunnar Operator Greetings. And welcome to the HeartBeam First Quarter 2024 Financial Results Conference Call.
seekingalpha.com
- 6 months ago
HeartBeam Reports First Quarter 2024 Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports First Quarter 2024 Results.
businesswire.com
- 6 months ago
8. Profile Summary
HeartBeam, Inc. BEAT
COUNTRY
US
INDUSTRY
Medical - Healthcare Information Services
MARKET CAP
$ 61.1 M
Dividend Yield
0.00%
Description
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
Contact
2118 Walsh Avenue, Santa Clara, CA, 95050
https://www.heartbeam.com
IPO Date
Nov. 11, 2021
Employees
15
Officers
Mr. Robert P. Eno
Chief Executive Officer & Chief Business Officer
Dr. Branislav Vajdic Ph.D.
Founder, President & Director
Dr. Peter J. Fitzgerald FACC, M.D., Ph.D.
Member of Scientific Advisory Board & Chief Medical Officer
Ms. Richa Gujarati
Senior Vice President of Product
Mr. Timothy Cruickshank
Chief Financial Officer
Mr. Kenneth Persen
Chief Technology Officer
Mr. Richard M. Ferrari
Executive Chairman